Special Issue "Advances in Nanoparticle-Mediated Drug Delivery"

A special issue of Scientia Pharmaceutica (ISSN 2218-0532).

Deadline for manuscript submissions: closed (30 November 2019).

Special Issue Editors

Dr. Murali Mohan Yallapu

Guest Editor
Department of Immunology and Microbiology, College of Medicine, University of Texas Rio Grade Valley, McAllen, TX 78503, USA
Interests: cancer therapy; drug delivery; drug targeting; infectious disease; micelle; nanoparticles; nanotechnology; polymers; targeted therapies; HIV; antibody engineering; antibody–drug conjugates
Special Issues and Collections in MDPI journals
Dr. Raghvendra A. Bohara

Guest Editor
CURAM, Center for Reasearch in Medical Devices, National University of Ireland Galway, Ireland
Interests: magnetic nanoparticles; cancer medicine; drug targeting; nanotechnology; polymers; targeted therapies
Dr. Varaprasad Kokkarachedu

Guest Editor
Centro de Investigación de Polímeros Avanzados, CIPA, Av.Collao 1202, Edificio Laboratorio CIPA Concepción, Chile
Interests: antibiotics; drug delivery; bionanomaterials for advanced biomedical; energy; environmental; industrial applications

Special Issue Information

Dear Colleagues,

Developments in fundamental knowledge and engineering sciences have helped the field of pharmaceutics. Nanotechnology-based materials are emerging as drug delivery carriers. This Special Issue entitled “Advances in Nanoparticle-Mediated Drug Delivery” from Scientia Pharmaceutica calls for cutting-edge research and review manuscripts dealing with insights of current developments of nanoparticles for targeted drug delivery. The issue will be focused on molecular drug targets, including disease-specific proteins, receptors, enzymes, and genes, which seek to elucidate the impact of new therapeutic agents on patient acceptability, preference, satisfaction, and quality of life.

Dr. Murali Mohan Yallapu
Dr. Raghvendra A. Bohara
Dr. Varaprasad Kokkarachedu
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Scientia Pharmaceutica is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 850 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • targeted drug delivery
  • nanoparticles
  • cancer nanomedicine
  • antibiotics
  • polymers

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Open AccessReview
Antioxidants in Cancer Therapy: Recent Trends in Application of Nanotechnology for Enhanced Delivery
Sci. Pharm. 2020, 88(1), 5; https://doi.org/10.3390/scipharm88010005 - 21 Jan 2020
Abstract
Recently, the occurrence of cancer has significantly increased; it represents the second-most frequent cause of death after cardiovascular diseases. Many dietary antioxidants have shown large impact as effective agents for cancer prevention by reducing oxidative stress, which has been a part in the [...] Read more.
Recently, the occurrence of cancer has significantly increased; it represents the second-most frequent cause of death after cardiovascular diseases. Many dietary antioxidants have shown large impact as effective agents for cancer prevention by reducing oxidative stress, which has been a part in the development of many diseases, including cancer. One of the obstacles in the delivery of antioxidant therapies into the required domain lies in the inadequate delivery of these agents to their intended site of action. Using nanotechnology in delivery of antioxidants leads to increased therapeutic index and higher drug concentration in tumor tissues, thus enhancing anticancer treatment. In this review, we discuss the role of different antioxidants in cancer therapy and their improved therapeutic effect through their formulation using nanotechnology. Full article
(This article belongs to the Special Issue Advances in Nanoparticle-Mediated Drug Delivery)
Back to TopTop